Viewing Study NCT06324994


Ignite Creation Date: 2025-12-25 @ 1:43 AM
Ignite Modification Date: 2026-01-02 @ 5:28 AM
Study NCT ID: NCT06324994
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-03-22
First Post: 2024-03-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Linperlisib Plus Obinutuzumab and Venetoclax for Relapsed and Refractory Blastoid Variant of Mantle Cell Lymphoma.
Sponsor: Dalian Medical University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module